Literature DB >> 16318676

Responses of the surface membrane and excretory system of Schistosoma mansoni to damage and to treatment with praziquantel and other biomolecules.

F A Oliveira1, J R Kusel, F Ribeiro, P M Z Coelho.   

Abstract

Damage to the surface membrane of adult Schistosoma mansoni, and the activity of the excretory system, as shown by resorufin fluorescence, was observed following treatment with praziquantel and incubation with other molecules. Praziquantel treatment induced damage to the surface membrane as measured by the use of a variety of fluorescent compounds. The excretory system of the male worm was inhibited immediately after praziquantel treatment, but fully recovered after culture for 2 h following removal of praziquantel. The excretory system of the female, observed to be minimally active in untreated worm pairs, was often greatly activated in paired females, as shown by intense resorufin labelling, after praziquantel treatment, and this continued during recovery of the male excretory system. In experiments with normal worm pairs, the female could be activated by inhibiting the metabolic rate of the pair by a cooling procedure. The effects on the excretory system of changes in culture conditions (such as changes in pH, concentrations of bacterial lipopolysaccharide, cytokines, reactive oxygen species, compounds which remove cholesterol, such as beta-methyl cyclodextrin, and damaging basic poly-L-lysine) were also assessed. It is concluded that the extensive excretory system of the adult worm is responsive to drug treatment and to certain changes in environmental conditions. Its activity seems to be strongly linked to the integrity of the surface membrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16318676     DOI: 10.1017/S0031182005009169

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

1.  Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel.

Authors:  Ravi S Kasinathan; William M Morgan; Robert M Greenberg
Journal:  Mol Biochem Parasitol       Date:  2010-05-12       Impact factor: 1.759

Review 2.  Pharmacology and potential physiological significance of schistosome multidrug resistance transporters.

Authors:  Ravi S Kasinathan; Robert M Greenberg
Journal:  Exp Parasitol       Date:  2011-03-21       Impact factor: 2.011

Review 3.  ABC multidrug transporters in schistosomes and other parasitic flatworms.

Authors:  Robert M Greenberg
Journal:  Parasitol Int       Date:  2013-03-06       Impact factor: 2.230

4.  Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility.

Authors:  Shanta M Messerli; Ravi S Kasinathan; William Morgan; Stefani Spranger; Robert M Greenberg
Journal:  Mol Biochem Parasitol       Date:  2009-05-03       Impact factor: 1.759

Review 5.  New approaches for understanding mechanisms of drug resistance in schistosomes.

Authors:  Robert M Greenberg
Journal:  Parasitology       Date:  2013-04-03       Impact factor: 3.234

6.  Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel.

Authors:  Ravi S Kasinathan; Tinopiwa Goronga; Shanta M Messerli; Thomas R Webb; Robert M Greenberg
Journal:  FASEB J       Date:  2009-09-02       Impact factor: 5.191

7.  Prevalence of schistosome antibodies with hepatosplenic signs and symptoms among patients from Kaoma, Western Province, Zambia.

Authors:  Lara Payne; Eleanor Turner-Moss; Mable Mutengo; Akwi W Asombang; Paul Kelly
Journal:  BMC Res Notes       Date:  2013-08-30

8.  Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.

Authors:  Regina Coeli; Elio H Baba; Neusa Araujo; Paulo M Z Coelho; Guilherme Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.